GlassScriptPhysician profile
Alexandra Levy
NPI 1528439445
$943.69
in general payments reported to CMS, 2019-2025
14 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2023: $302 · 2024: $273 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $283.18 | 2023-2024 | Mako, Insignia |
| Baxter Healthcare | $167.39 | 2021 | |
| Ethicon US, LLC | $119.75 | 2024 | Stratafix, Ethicon, Dermabond |
| C. R. Bard, INC. & Subsidiaries | $101.91 | 2023 | Arista Ah Flexitip |
| Pfizer INC. | $48.09 | 2025 | |
| Kestra Medical Technology Services, INC. | $34.11 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $31.39 | 2025 | Zerbaxa |
| Abbvie INC. | $26.74 | 2025 | |
| Depuy Synthes Sales INC. | $26.65 | 2023 | Orthovisc |
| Chiesi USA, INC. | $24.94 | 2025 | Mycapssa |
| Sanofi-Aventis U.S. LLC | $23.00 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.19 | 2025 | Xifaxan |
| Bioventus LLC | $20.03 | 2024 | Exogen Ultrasound Bone Healing System |
| Gilead Sciences, INC. | $14.32 | 2025 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.